Decision
Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
- Effect
- Passed
- Result
- 488 for · 67 against · 34 abstained roll call
- Date
- 10 April 2024, 19:22–19:23
- Kind
- New EU law · 1st reading
More facts (8)
- Margin
- by an overwhelming majority
- Text
- Report A-9-2024-0141
- Dossier
- 2023-0131
- Source
- Committee report by Tiemo Wölken
- Votes
- 40 votes · 6 roll calls · 5 amendments
- Requested by
- The Left (1 roll call) · ECR (5 split votes, 1 separate vote) · ID (1 roll call)
- Sitting
- Wednesday 10 April 2024
- Final vote
- 166879
Result
The final vote and what it means for this kind of decision.
Final vote: 488 for, 67 against, 34 abstained (roll call).
Passed by an overwhelming majority.
Parliament adopted its position on the law.
Before the final vote, MEPs decided on 5 amendments (5 rejected) and 8 parts of the text voted on separately (1 adopted, 7 rejected).
Backed by Greens, S&D, Renew, EPP and ECR; opposed by The Left, Patriots and ESN.
Groups
Members counted in their current group: the view with groups at the date of the vote is not available right now.
| Group | For | Against | Abst. | Majority line | Clear line | Bar |
|---|---|---|---|---|---|---|
| The Left | For 5 | Against 6 | Abst. 1 | Majority line Against | Clear line Divided | |
| Greens | For 27 | Against 1 | Abst. 0 | Majority line For | Clear line For | |
| S&D | For 57 | Against 1 | Abst. 0 | Majority line For | Clear line For | |
| Renew | For 38 | Against 0 | Abst. 0 | Majority line For | Clear line For | |
| EPP | For 75 | Against 1 | Abst. 1 | Majority line For | Clear line For | |
| ECR | For 15 | Against 10 | Abst. 0 | Majority line For | Clear line Divided | |
| Patriots | For 6 | Against 15 | Abst. 5 | Majority line Against | Clear line Divided | |
| ESN | For 0 | Against 4 | Abst. 0 | Majority line Against | Clear line Against | |
| No group | For 3 | Against 2 | Abst. 0 | Majority line For | Clear line Divided |
Voted against their group, 0
Members who voted otherwise than a clear line (at least two thirds of the votes cast) of their group — groups as of today: the view with groups at the date of the vote is not available right now.
Nobody voted against a clear line of their group.
Countries
The final vote by national delegation.
The breakdown by country is not available right now.
Members
Each member’s recorded position on the final roll call — groups as of today: the view with groups at the date of the vote is not available right now.
Debate speakers and how they voted
The debate speakers are not available right now.
All votes on this decision, 40
| No. | Vote | Recorded | Result | Requested by |
|---|---|---|---|---|
| 1 | Amendments by the committee responsible — put to the vote collectively Amendments by the committee responsible – put to the vote collectively | Show of hands | Adopted | |
| 2 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 3 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted |
Show the other 39 votesShow the other 37 votes
| No. | Vote | Recorded | Result | Requested by |
|---|---|---|---|---|
| 2 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 3 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted |
| No. | Vote | Recorded | Result | Requested by |
|---|---|---|---|---|
| 4 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 5 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 6 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 7 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 8 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 9 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 10 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 11 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Counted | 348 for, 222 against, 5 abstained Adopted | |
| 12 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 13 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 14 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 15 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 16 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 17 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 18 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 19 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 20 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 21 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 22 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 23 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 24 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 25 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 26 | Amendments by the committee responsible — separate vote Amendments by the committee responsible – separate vote | Show of hands | Adopted | |
| 27 | Separate vote on Article 30, paragraph 3 | Show of hands | Rejected | |
| 28 | Separate vote on Article 31, paragraph 1, introductory part | Show of hands | Rejected | |
| 29 | Separate vote on Article 31, paragraph 1, point b | Show of hands | Rejected | |
| 30 | Separate vote on Article 33, paragraph 2 | Show of hands | Rejected | |
| 31 | Separate vote on Article 33, paragraph 2 | Show of hands | Adopted | |
| 32 | Amendment 373 to Article 33, paragraph 3 A9-0141/2024 – Tiemo Wölken – Article 33, § 3 – Am 373 | Roll call | 129 for, 459 against, 1 abstained Rejected | Requested byroll call: ID |
| 33 | Separate vote on Article 33, after paragraph 3 | Show of hands | Rejected | |
| 34 | Separate vote on Article 34, paragraph 1 | Show of hands | Rejected | |
| 35 | Separate vote on Article 35, paragraph 1, point a | Show of hands | Rejected | |
| 36 | Amendment 379, adding text after Article 40 A9-0141/2024 – Tiemo Wölken – After Article 40 – Am 379 | Roll call | 156 for, 334 against, 98 abstained Rejected | Requested byroll call: The Left |
| 37 | Amendment 378 to Article 134, before paragraph 1 A9-0141/2024 – Tiemo Wölken – Article 134, before § 1 – Am 378 | Roll call | 96 for, 450 against, 36 abstained Rejected | Requested byroll call: The Left |
| 38 | Amendment 377, adding text after recital 3 A9-0141/2024 – Tiemo Wölken – After recital 3 – Am 377 | Roll call | 73 for, 504 against, 15 abstained Rejected | Requested byroll call: The Left |
| 39 | Amendment 368, adding text after recital 5 A9-0141/2024 – Tiemo Wölken – After recital 5 – Am 368 | Roll call | 62 for, 443 against, 59 abstained Rejected | Requested byroll call: ID |
| 40 | Final vote A9-0141/2024 – Tiemo Wölken – Commission proposal | Roll call | 488 for, 67 against, 34 abstained Adopted |
Roll calls requested by The Left, ID · split votes by ECR (5) · separate votes by ECR.
Text
The text voted on.
AI: The text in short Written by AI from the official text — check the source
Parliament's amended version of the Commission proposal for a regulation on authorising and supervising human medicines and on the European Medicines Agency. It adds rules on medicine shortages, environmental risk assessment, antimicrobial incentives, orphan and paediatric medicines, transparency and regulatory sandboxes.
Dossier
Where the dossier stands and its other decisions in plenary.
2023/0131(COD) · Ordinary legislative procedure
Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
Parliament’s committee approved the deal reached with the Council on 18 March 2026; the plenary vote on it is still to come.
Show the 6 steps of the dossier
- Referred to committee · 14 September 2023 (done)
- Committee work · Report adopted 19 March 2024 (done)
- Tabled for plenary · 21 March 2024 (done)
- Plenary vote · Adopted 10 April 2024 (done)
- Negotiations with the Council · Deal approved in committee 18 March 2026 (current stage)
- Published as law (to come)
Lead committee: ENVI · Rapporteur: Tiemo WÖLKEN (S&D)
Connections
What this decision touches: the procedural chain, the same text, running issues, votes that split the chamber the same way.
No connections found for this decision.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Official sources
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2024). “Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency”. Decision, 10 April 2024. votingId 166879, document A-9-2024-0141, reference 2023-0131. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32 (retrieved 25 September 2026). Official sources: Roll-call votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV_EN.html; Results of votes, sitting of 10 April 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-04-10/decisions?format=application%2Fld%2Bjson (CC BY 4.0).
BibTeX
@misc{epw-decision-2024-04-10-32,
author = {{European Parliament}},
title = {{Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency}},
year = {2024},
date = {2024-04-10},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32}},
url = {https://news.eu-parl.st-solutions.dev/decisions/2024-04-10/32},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Decision. votingId 166879, document A-9-2024-0141, reference 2023-0131. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-04-10-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-04-10 (CC BY 4.0)}
}